Zymewire
Zymewire provides a sales intelligence and prospecting platform for life sciences vendors, using machine learning to scan public and proprietary data to identify biopharma companies and clinical programs that are likely to need outsourced services, helping commercial teams prioritize and target accounts more effectively.
- Revenue
- <$10M
- Employees
- 51 - 200
- Founded
- 2012
- Headquarters
- Toronto, Canada
Zymewire customers on Arbolus
Customers who reviewed Zymewire
Seniority of Zymewire customers
Most people who reviewed Zymewire hold Director roles (62%), followed by C-Suite (38%).
- Director 62%
- C-Suite 38%
Customers sample
Employer names and spend open once the report publishes.
What 8 Arbolus experts think of Zymewire
Overall sentiment: Positive
NPS scores are high with a range of 7-9, and 2 of 5 respondents are clear Promoters (NPS 9). Renewal intent is documented for 2 out of 5, both positive and associated with longer-term use (>1 year). 40% of experts are at >1 year implementation, 20% at offboarding, and the remainder at less than 1 year or unsure. Key themes include strong satisfaction among long-term customers, moderate uncertainty among new or uncommitted users, and no negative outliers.
Tell us when the Zymewire report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
25 Net Promoter Score, from 8 scored reviews- Promoters 3
- Passives 4
- Detractors 1
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 50%Plan to renew, by seniority
- 100% 1 answer
- 0% 1 answer
- 9/10 Average score from customers who will renew
- 8/10 Average score from undecided customers
For people who use Zymewire
Do you use Zymewire at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 8 customers of Zymewire have already contributed
Takes a few minutes. Your identity stays anonymous.